- Home
- |
- About
- |
- Products
- |
- News and Media
- |
- Investors
- |
- Online Pharmacy
- |
- Contact Us
At Medicure, our mission is to serve patients by delivering safe and efficacious life-changing medicines. We are focused on improving the heart health of patients by offering a growing portfolio of cardiovascular products and ensuring all patients get access to therapy. Our commitment to service, partnership and integrity is what sets us apart.
The product information provided below is intended for residents of the U.S. only. To report an adverse event or a product complaint, or to request information about our products, please visit our Drug Safety or Medical Information pages.
AGGRASTAT (tirofiban hydrochloride) for injectionFollowing approval of a new dosing regimen in 2013, AGGRASTAT is the most widely used glycoprotein inhibitor in the United States. See Aggrastat Patents. |
|
ZYPITAMAG (pitavastatin) tabletsZYPITAMAG is a statin (HMG-CoA reductase inhibitor) medication approved by the U.S. Food and Drug Administration (FDA) in July 2017. See Zypitamag Patents. |
Leadership
Board of Directors
Our History
Mission and Values
Medicure Marks Its 25th Anniversary
People and Culture
Careers
AGGRASTAT® (tirofiban HCl) injection
Zypitamag®
Pipeline
Drug Safety
Medical Information
Patient Information
Events
Presentations / Conference Calls
Stock Information
Annual Reports
Quarterly Reports
Corporate Governance
Investor Contacts